Brickell Biotech Inc (NASDAQ:BBI)
| 1.48 Delayed Data As of 2:17pm ET |  -0.0124 / -0.83%Today’s Change | 1.22 Today|||52-Week Range 8.96 | -1.49% Year-to-Date |
Latest BBI News | Press Releases
No recent news for Brickell Biotech Inc.
Today’s Trading
| Previous close | 1.49 |
| Today’s open | 1.49 |
| Day’s range | 1.45 - 1.54 |
| Volume | 137,344 |
| Average volume (3 months) | 79,722 |
| Market cap | $13.0M |
Data as of 2:17pm ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | +26.32% |
| Earnings growth (this year) | +48.65% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -88.26% |
| P/E ratio | NM |
| Price/Sales | 15.89 |
| Price/Book | 0.11 |
Competitors
| ---- | ||
| TNXPTonix Pharmaceutical... | +0.18 | +12.95% |
| CBLICleveland Biolabs In... | +0.02 | +1.99% |
| ATHEAlterity Therapeutic... | +0.02 | +2.43% |
Data as of 2:35pm ET, 01/24/2020
Financials
| Next reporting date | March 11, 2020 |
| EPS forecast (this quarter) | $0.00 |
| Annual revenue (last year) | $1.6M |
| Annual profit (last year) | -$16.3M |
| Net profit margin | -1,002.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
